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Abstract
Objectives: We sought to determine the frequency and outcomes with symptomatic arrhythmia 
in  patients  with  apical  ballooning  syndrome  (ABS).                             
Methods: A retrospective review of the Mayo Clinic Angiography database was conducted to 
identify patients  who met  the Mayo criteria  for ABS. Patients  with documented arrhythmias 
formed the study group, and 31 randomly selected patients with ABS but without arrhythmia 
formed  the  control  group.                                        
Results: Out  of  105  patients  identified  with  ABS,  6  (5.7%)  women  aged  69  +/-  9  years 
experienced  significant  arrhythmia  (ventricular  fibrillation,  asystole),  2  patients  died,  and  1 
required permanent  pacemaker  implantation.  When compared  with controls,  the study group 
showed no significant difference with respect to  ECG  characteristics (QT, QRS duration or 
axis)  except  for  R-R  interval  variability  (see  comments  below)  (30.6±6  vs  14.5±17  p  = 
0.0004), QTc, and P-R interval. Patients without arrhythmia were more likely to be on  beta-
blocker therapy than the study population (33% vs 80.6% p = 0.02).                                
Conclusion: Life-threatening  arrhythmia  is  uncommon  (5.7%)  with  ABS  despite  marked, 
structural abnormalities. When arrhythmias do occur, the outcome is poor.  Prominent variability 
in R-R intervals appears to be predictive of significant arrhythmias in ABS.  The role of beta-
blocker therapy in preventing arrhythmia with ABS requires further investigation. 
Key Words: apical ballooning, Takotsubo cardiomyopathy, arrhythmia, sudden death, 
ventricular fibrillation, atrioventricular block 
Introduction
            Apical  ballooning  syndrome  (ABS)  also  referred  to  as  Takotsubo  or  stress 
cardiomyopathy is characterized by symptoms of myocardial ischemia, ST segment and T wave 
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abnormality  along  with  transient  ventricular  wall  motion  abnormalities  in  the  absence  of 
significant  coronary  artery  stenosis1,2.  There  have  been  anecdotal  reports  for  significant 
arrhythmias in patients with ABS3,4, but the exact association, if any, of ABS with malignant 
arrhythmias is unknown. While ABS shares several similarities with acute coronary syndromes 
including QT interval prolongation and increased QT dispersion in the subacute phase5, life-
threatening arrhythmias and permanent conduction abnormalities appear to be less common.  
            Several studies comparing ABS with myocardial ischemia have found similarities in the 
ST segment and T wave changes including the time course of these changes in both sets of 
patients.  An  important  distinction  in  the  electrocardiographic  findings  between  myocardial 
ischemia in ABS was recently reported6. Rate adaptation of ventricular repolarization, that is, the 
dynamicity  of  QT  interval  modulation  in  response  to  changes  in  heart  rate,  appears  to  be 
preserved  in  patients  with  ABS  but  is  significantly  affected  in  patients  with  myocardial 
infarction.  
            The aim of our study was to determine the incidence, significance,  and outcomes of 
malignant brady- and tachyarrhythmia in patients with a definitive diagnosis of ABS. We further 
explored the potential contribution of the lack of effect of 24-hour R-R interval   variability  on 
repolarization.
Materials  and  Methods                                      
Study  population                                        
            The  Mayo  Clinic  Cardiac  Catheterization  database  was  retrospectively  reviewed  to 
identify patients who underwent coronary arteriography and left ventriculography and met the 
Mayo Clinic criteria (Table 1)7 for diagnosis of ABS from January 1988 to November 2003. In 
addition,  patients  were  enrolled  prospectively  from  November  2003  to  October  2006.  We 
initially  identified  550  patients  without  obstructive  coronary  disease  and  wall  motion 
abnormality sparing the basal segments. Out of 550 patients, 421 were excluded because of a 
diagnosed  cardiomyopathy,  valvular  disease,  congenital  heart  disease,  phaeochromocytoma, 
cocaine abuse, paced heart rhythm, or active myocarditis. Of the remaining 129 patients, 107 
met the Mayo Clinic criteria for diagnosis of ABS7 with documented complete normalization of 
left ventricular function on follow-up echocardiography, 2 patients could not be contacted, and 
the remaining 105 patients formed the study population.  
Table 1: Mayo Clinic Criteria for the Clinical Diagnosis of Apical Ballooning Syndrome
*Rare  exceptions  to  these  criteria  exist.  †The  possibility  of  ABS  developing  along  with  obstructive  coronary 
atherosclerosis  may rarely need consideration.                                                               
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In either of the above circumstances,  the diagnosis of apical  ballooning syndrome should be 
made with caution, and evidence for a clear stressful precipitating figure must be sought.  
Data  collection                                           
            The  complete  medical  record  with  particular  emphasis  on  historical  features, 
medications, and 12-lead electrocardiograms were reviewed in the study population.                
            Initial  echocardiography  was  performed  without  knowledge  of  patient  outcome  or 
eventual  diagnosis.  Each  echocardiogram of  the  patients  in  this  series  was  reviewed by an 
independent echocardiologist who was blinded to patient outcome in this study. All diagnoses 
based on the echocardiographic features were found by both echocardiologists to be consistent 
with  ABS.                                                   
Electrocardiographic  analysis                                          
            Manual measurement of the P wave duration, PR, QT, and R-R intervals were made. 
Bazett's formula was used to calculate the corrected QT interval8. QT variability was measured 
as the absolute difference in the QT interval in lead V1 from the QT interval in lead V6. This 
was done to understand the regional  variation in repolarization given the regionality of wall 
motion abnormality in patients  with ABS.  The PR interval  was indexed to the heart  rate to 
discount the potential effect of heart rate variation on AV nodal conduction. Each patient had a 
minimum of four electrocardiograms analyzed of which at  least  1 was in the first  24 hours 
following diagnosis.  Holter  monitoring,  telemetry,  and other  electrocardiographic  data,  when 
available, were analyzed. R-R interval variability was determined as the difference between the 
maximum  and  minimum  heart  rate  during  the  24  hours  following  diagnosis  of  ABS.  
Study  and  control  group                                      
            Six patients with ABS were identified with life- threatening arrhythmia and formed the 
study group, and 31 patients were randomly selected from the remaining 99 patients without a 
fatal  or  life-threatening  arrhythmia  and  formed  the  control  group.  The  electrocardiographic 
parameter  review and analysis  was performed in a blinded fashion as to whether or not the 
patient  had  malignant  arrhythmia.                                           
            The cause of death was confirmed using all available clinical data at the time of death 
and by reviewing the issued death certificates.  The study was approved by the Mayo Clinic 
Institutional Review Board for Human Research and included only patients who gave consent 
for  their  medical  records  to  be  utilized  for  research.                                 
Statistical  analysis                                            
            Descriptive statistics are reported as frequencies and percentages for categorical data and 
the mean ± standard deviation for continuous data.  Comparisons between patient groups were 
performed with the Student t test for independent, categorical variables.  Follow-up events are 
reported  as  individual  occurrences  and  estimated  using  the  Kaplan-Meier  method  where 
applicable.   
 
Results
Study  group                                                  
            Out of 105 patients with ABS (5.7%), 6 were found to have life- threatening arrhythmias 
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and formed the study group.  All patients were females with mean age of 69 ± 8.9 years (Table 
2). Salient features include the average heart rate at presentation 89 ± 26.8 bpm, P wave duration 
100 ± 20 ms, PR interval 207 ± 96 ms, PR index 2.1 ± 1.4 ms/beat, QT interval 405 ± 85 ms, 
QTc 491 ± 81 ms, QT dispersion 78 ± 40.2 ms, regional QT variability (QT in lead V6 – QT in 
lead V1) 11 ± 23.4, and maximal 24-hour R-R interval variation 30.6 ± 6 ms (Table 3). The 
median  and  interquartile  range  from  time  from  onset  of  symptoms  to  ECG  was  100  and 
12.5-338.5 minutes.
Table 2: ABS and Malignant Arrhythmia: Patient Characteristics
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Table 3: Malignant Arrhythmia and ABS: Risk Factors
            Out of the 6 patients who presented with ventricular fibrillation, 2 were first diagnosed 
with  ABS following resuscitation. Patient 1 had sinus pauses at presentation with ABS up to 7.4 
seconds in duration. The clinical course was later complicated by asystole requiring resuscitation 
that  included  temporary  pacemaker  implantation  and inotropic  support  with  gradual  clinical 
improvement.  Patient 2 had a documented cardiac arrest 4 days after diagnosis with ABS. The 
QTc was 399 ms  3 hours  prior  to  her  arrest.  The patient  did have a  prior  history of  atrial 
fibrillation  but  was  not  monitored  electrocardiographically  at  the  time  of  cardiac  arrest. 
Ventricular  fibrillation  was  documented  during  attempted  resuscitation  that  failed  with  the 
patient  dying.  Patient  3 had  a  prior  history  of  multifocal  atrial  tachycardia  and  pacemaker 
implantation and presented with ventricular fibrillation. The patient recovered completely and 
was discharged home uneventfully 9 days following diagnosis but died following sudden cardiac 
arrest 3 days following hospital discharge.  Patient 4 presented with unexplained collapse and 
documented ventricular fibrillation. Following resuscitation, a diagnosis of ABS was made. The 
patient  gradually  improved  and  was  discharged  with  subsequent  complete  normalization 
echocardiographically and clinically at 7 months post episodes. Patient 5 presented with anginal 
chest pain, and admission  ECG  showed Mobitz I AV block and right bundle-branch block at 
the time of diagnosis with ABS.  One week following hospitalization, worsening of Mobitz I 
block along with evidence of sinus node dysfunction was found. EP study showed no evidence 
of infra-Hisian conduction disease. The patient had completely recovered but with persisting 
right bundle-branch block and Mobitz I AV block 16 months following ABS diagnosis. Patient  
6 had electrocardiographically documented Mobitz II AV block with ventricular rate of 32 bpm. 
Permanent pacemaker implantation was performed, and the remainder of her hospital course was 
uneventful  with complete  recovery of wall  motion  abnormalities  at  follow-up up to  7 years 
following  initial  diagnosis.                                           
Control  group                                                 
            Thirty-one patients with diagnosed ABS without significant arrhythmia constituted the 
control group. All patients were female with mean age of 68.2 +/- 12 years, average heart rate of 
86.5 +/- 21 bpm, PR interval of 162 +/- 24 ms, QT interval of 366.4 +/- 52 ms, QTc interval of 
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433.7 +/- 25 ms, and maximal 24-hour R-R interval variation of 14.5 +/- 17 ms. The median and 
interquartile  range from time from onset of symptoms to ECG was 240 and 5-870 minutes.
Differences in study and control groups                                                 
            In  comparing  the  patients  with  and  without  malignant  arrhythmia,  there  was  no 
statistically significant difference in the heart rate at presentation (89±26.8 vs 86.5±21.2, p = 
0.8), P wave axis (73.3±13.3 vs 57.6±17.7, p = 0.1), QT interval (405.3±84.7 vs 366.4±52.3, p = 
0.1), QT index (4.55±6.39 vs 5.09±10.41, p = 0.9), QT dispersion (78±40.2 vs 63.3±26.7, p = 
0.2), regional QT variability (11±23.4 vs 15.5±34.1, p = 0.8), PR index ( 2.1±1.4 vs 1.95±0.6, p 
= 0.5), or time of onset of symptoms to ECG (median 100 vs 240, p = 0.2) (Figure 1).
Figure 1: Upper panel:  There was no significant difference in the baseline QT interval between patients with ABS 
with and without  malignant  arrhythmia.  However,  the corrected  QT interval  was significantly different,  being 
higher in the patients with arrhythmias (see text for details). Lower panel:  There was a significant difference in the 
PR interval in the study versus control group.  The PR interval was longer in patients with arrhythmia and ABS.  
When the PR interval was indexed for the heart rate, there was no difference in the two groups.  This suggests that 
at higher sinus rates, the PR interval shortened in ABS patients with arrhythmias.  This in turn suggests that the 
cause of AV delay was at the level of the compact AV node, and conduction improved during catecholamine stress 
(see text for details).
            There was a statistically significant difference between these 2 groups in maximal R-R 
interval variation (30.6±6 vs 14.5±17, p = 0.0004), QTc interval (490.5±80.8 vs 433.7±25.4, p = 
0.0025), and PR interval (207±95.9 vs 162±24.3, p = 0.02) (Figure 2).  
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Figure 2: The maximal R-R interval variation at first evaluation was significantly greater in patients who developed 
life-threatening arrhythmia  when compared to the control  group with ABS and no significant  arrhythmia.  This 
finding,  coupled  with  our  observation  of  longer  corrected  QT  interval  in  the  study  group  suggests  potential 
mechanism for arrhythmogenicity in ABS patients who developed documented malignant arrhythmia.  
            Clinical characteristics at baseline were similar in the control and study groups (age, sex, 
hypertension, diabetes). Patients in the study group, however, had a higher prevalence of atrial 
fibrillation (66.6% vs 9.6% p = 0.001) and were less likely to be on beta-blocker therapy at the 
time of presentation (2/6 [33.3%] vs.  25/31 [80.6%] p = 0.02).                             
Discussion
    
            Since its  recent  description as a clinical  entity characterized by transient  ventricular 
dysfunction in the setting of chest pain, ST segment, and T wave abnormalities in the absence of 
occlusive  coronary  artery  disease,  apical  ballooning  syndrome  has  become  the  subject  of 
significant investigation1,2,5,6. While important advances have been made in understanding the 
extent  of  myocardial  involvement1,2,  potential  pathogenic  mechanisms,  and distinctions  with 
ischemic syndromes1,3,5,6, little is known about the risk and outcomes associated with arrhythmia 
(bradycardic and tachycardic) occurring in the setting of ABS.                              
            Previous reports have shown that although the type of changes in the 12-lead surface 
electrocardiogram and the time course of these ECG  changes in ABS are similar to those seen in 
patients with a myocardial infarction5,9,  malignant arrhythmias are much less common in ABS. 
Matsuoka et al5 reported the absence of sudden cardiac death and other malignant ventricular 
arrhythmia  in  patients  with  ABS  even  though  electrocardiographic  abnormality  including 
significantly prolonged QT intervals  and QT dispersion persisted for several  weeks after  the 
index event. A few prior reports have, however, demonstrated occasional apparent association 
between ABS and both significant bradyarrhythmia and tachycardia3,4.                           
            In our study population of 105 patients  diagnosed with ABS based on Mayo Clinic 
criteria,  6  patients  (5.7%)  experienced  life-threatening  arrhythmia  and/or  conduction 
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abnormality.  There was no significant difference in these patients with malignant arrhythmia 
compared to a control population (ABS without arrhythmia) with regard to clinical presentation, 
age,  sex  and  other  clinical  parameters.  We  did,  however,  find  several  important 
electrocardiographic  and  previous  history  differences  that  may  provide  clues  to  the 
pathophysiology of ABS and point to treatment options to decrease risks of these arrhythmias.   
Maximal  RR  interval  variation                                              
            We report that patients with ABS who had malignant arrhythmia had significantly more 
variation in their R-R intervals (maximal R-R interval - minimum R-R interval in the first 24 
hours of admission) compared with the control group. A recent report by Bonnemeier et al6 may 
help explain our findings. In their study6, patients with ABS continued to show modulation of 
the QT interval with changes in the heart rate even during the acute phase of the syndrome. This 
was  in  contradistinction  to  the  absence  of  such  modulation  in  patients  with  myocardial 
infarction10. Thus, when malignant arrhythmias occur in myocardial infarction, they are likely as 
a result of ischemia itself, whereas in apical ballooning syndrome should a patient have prior QT 
prolongation or have significant heart rate variation, they would likely have more prominent QT 
interval changes that may increase the propensity for malignant arrhythmia (Figure 3).  
Figure 3: All patients in the study and control group met our published criteria for ABS.  Although all patients had 
the typical transient ST segment and T wave changes at the time of documented wall motion abnormality, patients 
who developed malignant arrhythmia had greater variation in the R-R intervals along with a longer corrected QT 
interval (see text for details).  
Prior  arrhythmia                                               
            We found a significant increase in prior arrhythmia in patients with ABS who developed 
malignant  arrhythmia.  Three  patients  had  prior  atrial  fibrillation,  and  1  patient  each  with 
multifocal atrial tachycardia, variable AV node dysfunction, and sinus node dysfunction. Each of 
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these  conditions  increases  the  variability  of  ventricular  activation  (variable  heart  rate).  As 
discussed above,  with the  recently  demonstrated  continued presence of QT modulation  with 
heart  rate  variation,  these  prior  arrhythmias  may  have  contributed  to  the  study  group's 
predilection  for  malignant  arrhythmia.                                       
PR  and  QT  intervals                                  
            In our study, we found a statistically significant difference in the PR intervals between 
the 2 groups, yet there was no difference once we corrected for heart rate (PR index).  Thus, the 
patients with the longer PR intervals had concomitant slower heart rates.  This finding suggests 
that  the  PR  prolongation  is  not  from  intrinsic  AV  nodal  conduction  disease  but  from 
sympathovagal imbalance as a previously suggested abnormality in ABS11. Structural AV nodal 
disease  as  potentially  from  transient  disturbances  in  the  microcirculation  as  previously 
suggested4 would have resulted in longer PR intervals at faster heart rates and is contrary to our 
finding. We further found evidence in our 2 patients with AV block that support a predominant 
catecholamine surge is important in the pathogenesis of ABS. In the patient with Mobitz I AV 
block and EP study proven absence of intra-Hisian conduction disease, there appeared to be 
transient improvement in AV conduction in the acute phase of the syndrome. On the other hand, 
in the patient with Mobitz II AV block (infra-Hisian), the condition was worsened in the acute 
phase.  This  type  of response in  AV block is  consistent  with catecholamine  stimulation12.   
    
            We also found in our study that the QT interval  corrected for heart  rate (QTc) was 
significantly longer in patients at risk for malignant arrhythmia even though the absolute QT 
interval showed no difference.  This finding suggests that in our study group, the longer QT 
interval occurred in patients with relatively faster heart rates, a finding similar to that observed in 
ischemic  heart  disease.  As  discussed  previously,  because  of  the  preserved  QT modulatory 
defects of heart rates in ABS6 (as opposed to its absence in ischemic heart disease), this may 
have further contributed to arrhythmogenesis seen in our patients with marked rate variability. A 
second explanation may be that because the malignant arrhythmias occurred in our patients with 
marked variation in their heart rate, the standard correction for QT intervals at extremes of heart 
rate may have been inaccurate. It is possible that in a few patients who had cardiac arrest or other 
severe medical illness/dyselectrolytemia that the QTc at the time of the measurement used in our 
study may have been affected. Whenever possible, pre-event (cardiac arrest) electrograms were 
used  to  obtain  baseline  data.                                         
Beta-blocker  use                                           
            An unanticipated finding in our study was the statistically significant difference in beta-
blocker use in the study group 2/6 (33.3%) versus the control group 25/31 (80.6%), p value 
0.02.  While this result should be interpreted with caution given the relatively small number of 
patients in the study group, it nevertheless is consistent with the hypothesis that marked variation 
in heart rate may be the primary factor increasing the risk for malignant arrhythmia in patients 
with  ABS.  If  further  studies  also  show  such  a  protective  effect  of  beta-blockers,  then 
recommending these drugs for long-term use following recovery may be considered given the 
nonnegligible  recurrence  rate  for  ABS (11.4% at  4-year  follow-up1).                      
            Another  incidental  finding  of  potential  significance  from our  study was  the  higher 
prevalence  of  atrial  fibrillation  (66% vs.  9.6%, p=0.001)  in  the study group with  malignant 
arrhythmia  compared  to  the control  group. Based on the above discussion on preserved QT 
dynamicity in ABS patients, the reason for this increased prevalence of atrial fibrillation may be 
as a result of prominent R-R interval variability from this disease, in turn producing significant 
ventricular arrhythmia. Alternative possibilities include preexisting conduction abnormalities in 
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patients with atrial  fibrillation (sick sinus syndrome) or a previously unproven association of 
atrial  fibrillation  with  ABS.                                             
            Thus, while our study shows that malignant arrhythmias are uncommon in patients with 
ABS, they do occur, and marked heart rate variability and previously diagnosed arrhythmia may 
be risk factors for their development while beta-blocker use may be protective. Our study was 
too small to comment on ICD benefit. However, in one patient who had a resuscitated event, 
secondary  prophylaxis  could  have  been  considered  and  may  have  prevented  his  event.  
   
Limitations
            A portion of our study was conducted in a retrospective fashion, and thus some data 
relevant to arrhythmias may have not been collected at the time of diagnosis. We did perform, 
however, a careful chart review and all saved electrocardiographic and rhythm monitoring data 
to  try  and offset  this  weakness  in  our  study.                                            
            We used the simple difference between maximal and minimal R-R intervals during 24-
hours to assess for R-R interval variability in our study. A more robust method of looking at 
heart rate variability would have been superior given the importance of this finding in our study. 
However, similar  measurements in both the control and study group were made in a blinded 
fashion, thus the reported association is likely accurate.                                      
            Another  limitation  of  our  study  is  that  we  have  grouped  arrhythmias  of  varying 
pathophysiology  as  malignant  arrhythmias  and  defined  our  study  group  accordingly.  The 
majority of the patients did have ventricular fibrillation, but as noted in our discussion, AV nodal 
block may accentuate the propensity for ventricular arrhythmia as well.  In addition, our findings 
that prior beta-blocker use was protective and that marked R-R interval variability was predictive 
of  arrhythmic  events  regardless  of  whether  these  were  tachyarrhythmic  or  bradyarrhythmic 
constituted  the  rationale  for  this  grouping.                                               
            In our study, we excluded many patients (421/550 [76.5%]) with likely ABS when a 
concomitant cardiac diagnosis (dilated cardiomyopathy, etc.) was present. In practice, patients 
with  these  previous  comorbidities  may  develop  ABS,  and  the  risk  factors  for  malignant 
arrhythmia and possible protective effect of beta-blockade may be different from our findings.  
Conclusion
            To our knowledge, this is the first report in a relatively large series of confirmed ABS 
patients on the occurrence of malignant arrhythmias specifically comparing patients with such 
arrhythmias  with control  patients  with ABS but  without  clinical  arrhythmia.  We found that 
marked 24-hour R-R interval variation and prior history of arrhythmia increased the propensity 
for malignant arrhythmia in patients with ABS, and beta-blocker use decreases the risk of such 
arrhythmia.  
            If future, larger studies confirm these observations,  then more careful monitoring of 
patients with ABS, prior arrhythmia,  and marked heart rate variation is warranted,  and beta-
blocker use can be recommended particularly in anticipation of possible recurrent ABS.  
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 8 (3): 182-192 (2008)
Chadi Dib, Abhiram Prasad, Paul A. Friedman, Ahmad Elesber,                              192  
Charanjit S. Rihal, Stephen C. Hammill, Samuel J. Asirvatham, “Malignant Arrhythmia in 
Apical Ballooning Syndrome: Risk Factors and Outcomes” 
References
1. Elesber AA, Prasad A, Bybee,  KA et al.,  Transient Cardiac Apical Ballooning Syndrome: 
Prevalence and Clinical Implications of Right Ventricular Involvement. Journal of the American 
College  of  Cardiology,  2006.  47:  1082-1083.                               
2. Haghi D, Athanasiadis A, Papavassiliu T et al., Right ventricular involvement in Takotsubo 
cardiomyopathy.  European  Heart  Journal,  2006.  27:2433-2439.                           
3. Kurisu S, Inoue I, Kawagoe T et al., Time course of electrocardiographic changes in patients 
with  tako-tsubo-like  syndrome:  comparison  with  acute  myocardial  infarction  with  minimal 
enzymatic  release.  Circ  J,  2004.  68:77-81.                                    
4. Nef HM, Mollmann H, Sperzel J et al., Temporary third-degree atrioventricular block in a 
case of apical ballooning syndrome. International Journal of Cardiology, 2006. 113: E33-E35.  
5. Matsuoka K, Okubo S, Fujii E et al., Evaluation of the arrhythmogenecity of Stress-Induced 
"Takotsubo cardiomyopathy" from the time course of the 12-lead surface electrocardiogram. The 
American  Journal  of  Cardiology,  2003.  92: 230-233.                                      
6.  Bonnemeier H, Ortak J, Bode F et al., Modulation of Ventricular Repolarization in Patients 
with  Transient  Left  Ventricular  Apical  Ballooning:  A  Case  Control  Study  Journal  of 
Cardiovascular  Electrophysiology,  2006.  17:  1340-1347.                                 
7. Prasad  A.  Apical  Ballooning  Syndrome:  An  Important  Differential  Diagnosis  of  Acute 
Myocardial  Infarction.  Circulation,  2007.  115:.  e56-e59.                              
8. Bazzett JC. An Analysis of time relations of electrocardiograms. Heart, 1920. 7: 353-367.     
9.  Ogura R, Hiasa Y, Takahashi T et al., Specific Findings of the Standard 12-Lead ECG in 
Patients  With Takotsubo Cardiomyopathy:  Comparison With the Findings of Acute Anterior 
Myocardial Infarction. Circ J, 2003. 67: 687-690.                                              
10. Nahshoni E, Strasberg B, Adler E, Imbar S, Sulkes J, Weizman A et al., Complexity of the 
dynamic  QT variability  and  RR  variability  in  patients  with  acute  anterior  wall  myocardial 
infarction: a novel technique using a non-linear method. J Electrocardiol, 2004. 37: 173-9.    
11. Wittstein IS, Thiemann DR, Lima JA et al., Neurohumoral Features of Myocardial Stunning 
Due  to  Sudden  Emotional  Stress.  N  Engl  J  Med,  2005.  352:  539-548.                  
12. Victor J, Foussard C, Laporte J, Bouvier JM, Tadei A et al., [Influence of the autonomic 
nervous system on the normal and pathological atrioventricular node]. Archives des Maladies du 
Coeur et des Vaisseaux, 1987. 80: 1471-7.
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 8 (3): 182-192 (2008)
